Effects of lamivudine on the function of dendritic cells derived from patients with chronic hepatitis B virus infection

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 34

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

294

HTML

1928

Figures (1-2)

227

Tables (1-2)

189

Sum=2638

Sep 14, 2007 (publication date) through Nov 30, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Rapid Communication

World J Gastroenterol. Sep 14, 2007; 13(34): 4641-4645
Published online Sep 14, 2007. doi: 10.3748/wjg.v13.i34.4641

Table 2 The stimulatory ability of DCs treated with LAM in allogeneic mixed leukocyte reactions (mean ± SD, n = 15)

SI: Stimulator index; DC: Dendritic cell; LAM: Lamivudine.

^aP < 0.05 vs control group.

Citation: Zheng PY, Zhang DY, Lu GF, Yang PC, Qi YM, Wang BS. Effects of lamivudine on the function of dendritic cells derived from patients with chronic hepatitis B virus infection. World J Gastroenterol 2007; 13(34): 4641-4645
URL: https://www.wjgnet.com/1007-9327/full/v13/i34/4641.htm
DOI: https://dx.doi.org/10.3748/wjg.v13.i34.4641